tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market

Oncopeptides AB (ONCO) Cash flow

Compare
0 Followers

Oncopeptides AB Cash Flow

SE:ONCO's free cash flow for Q4 2024 was kr-71.50M. For the 2024 fiscal year, SE:ONCO's free cash flow was decreased by kr19.04M and operating cash flow was kr-71.50M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -260.57Mkr -279.49Mkr -420.51Mkr -1.52Bkr -1.30B
Investing Cash Flow
kr 496.00Kkr -116.00Kkr -2.51Mkr -339.00Kkr -20.13M
Financing Cash Flow
kr 263.81Mkr 106.89Mkr 392.40Mkr 1.03Bkr 1.32B
End Cash Position
kr 178.54Mkr 173.41Mkr 344.51Mkr 362.19Mkr 840.25M
Free Cash Flow
kr -260.57Mkr -279.61Mkr -423.02Mkr -1.52Bkr -1.31B
Currency in SEK

Oncopeptides AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis